SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-072598
Filing Date
2024-08-26
Accepted
2024-08-26 16:15:34
Documents
17
Period of Report
2024-08-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0212260-8ka1_citius.htm   iXBRL 8-K/A 54614
2 UNAUDITED FINANCIAL STATEMENTS OF SPINCO AS OF AND FOR THE NINE MONTHS ENDED JUN ea021226001ex99-1_citius.htm EX-99.1 143420
3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA ea021226001ex99-2_citius.htm EX-99.2 58747
4 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION AS OF AND FOR THE S ea021226001ex99-3_citius.htm EX-99.3 166255
  Complete submission text file 0001213900-24-072598.txt   699247

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tenku-20240812.xsd EX-101.SCH 3267
6 XBRL DEFINITION FILE tenku-20240812_def.xml EX-101.DEF 26193
7 XBRL LABEL FILE tenku-20240812_lab.xml EX-101.LAB 35952
8 XBRL PRESENTATION FILE tenku-20240812_pre.xml EX-101.PRE 24851
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0212260-8ka1_citius_htm.xml XML 5386
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6677
CITIUS ONCOLOGY, INC. (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41534 | Film No.: 241241471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)